These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
679 related articles for article (PubMed ID: 27959717)
1. Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease. Hiatt WR; Fowkes FG; Heizer G; Berger JS; Baumgartner I; Held P; Katona BG; Mahaffey KW; Norgren L; Jones WS; Blomster J; Millegård M; Reist C; Patel MR; N Engl J Med; 2017 Jan; 376(1):32-40. PubMed ID: 27959717 [TBL] [Abstract][Full Text] [Related]
2. Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease. Jones WS; Baumgartner I; Hiatt WR; Heizer G; Conte MS; White CJ; Berger JS; Held P; Katona BG; Mahaffey KW; Norgren L; Blomster J; Millegård M; Reist C; Patel MR; Fowkes FG; Circulation; 2017 Jan; 135(3):241-250. PubMed ID: 27840336 [TBL] [Abstract][Full Text] [Related]
3. Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial. Berger JS; Katona BG; Jones WS; Patel MR; Norgren L; Baumgartner I; Blomster J; Mahaffey KW; Held P; Millegård M; Heizer G; Reist C; Fowkes FG; Hiatt WR Am Heart J; 2016 May; 175():86-93. PubMed ID: 27179727 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial. Norgren L; Patel MR; Hiatt WR; Wojdyla DM; Fowkes FGR; Baumgartner I; Mahaffey KW; Berger JS; Jones WS; Katona BG; Held P; Blomster JI; Rockhold FW; Björck M; Eur J Vasc Endovasc Surg; 2018 Jan; 55(1):109-117. PubMed ID: 29273390 [TBL] [Abstract][Full Text] [Related]
5. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial. Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857 [TBL] [Abstract][Full Text] [Related]
6. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. Wallentin L; Becker RC; Budaj A; Cannon CP; Emanuelsson H; Held C; Horrow J; Husted S; James S; Katus H; Mahaffey KW; Scirica BM; Skene A; Steg PG; Storey RF; Harrington RA; ; Freij A; Thorsén M N Engl J Med; 2009 Sep; 361(11):1045-57. PubMed ID: 19717846 [TBL] [Abstract][Full Text] [Related]
7. Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study. Kohli P; Wallentin L; Reyes E; Horrow J; Husted S; Angiolillo DJ; Ardissino D; Maurer G; Morais J; Nicolau JC; Oto A; Storey RF; James SK; Cannon CP Circulation; 2013 Feb; 127(6):673-80. PubMed ID: 23277305 [TBL] [Abstract][Full Text] [Related]
8. Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. Kang HJ; Clare RM; Gao R; Held C; Himmelmann A; James SK; Lim ST; Santoso A; Yu CM; Wallentin L; Becker RC; Am Heart J; 2015 Jun; 169(6):899-905.e1. PubMed ID: 26027629 [TBL] [Abstract][Full Text] [Related]
9. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809 [TBL] [Abstract][Full Text] [Related]
10. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial. Patel MR; Becker RC; Wojdyla DM; Emanuelsson H; Hiatt WR; Horrow J; Husted S; Mahaffey KW; Steg PG; Storey RF; Wallentin L; James SK Eur J Prev Cardiol; 2015 Jun; 22(6):734-42. PubMed ID: 24830710 [TBL] [Abstract][Full Text] [Related]
12. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. Cannon CP; Bhatt DL; Oldgren J; Lip GYH; Ellis SG; Kimura T; Maeng M; Merkely B; Zeymer U; Gropper S; Nordaby M; Kleine E; Harper R; Manassie J; Januzzi JL; Ten Berg JM; Steg PG; Hohnloser SH; N Engl J Med; 2017 Oct; 377(16):1513-1524. PubMed ID: 28844193 [TBL] [Abstract][Full Text] [Related]
13. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack. Johnston SC; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Jonasson J; Minematsu K; Molina CA; Wang Y; Wong KS; N Engl J Med; 2016 Jul; 375(1):35-43. PubMed ID: 27160892 [TBL] [Abstract][Full Text] [Related]
14. Initial experience with ticagrelor in patients with critical limb ischemia and high on-clopidogrel platelet reactivity undergoing complex peripheral endovascular procedures. Spiliopoulos S; Katsanos K; Pastromas G; Diamantopoulos A; Kitrou P; Siablis D; Karnabatidis D Cardiovasc Intervent Radiol; 2014 Dec; 37(6):1450-7. PubMed ID: 24510279 [TBL] [Abstract][Full Text] [Related]
15. Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. Husted S; James S; Becker RC; Horrow J; Katus H; Storey RF; Cannon CP; Heras M; Lopes RD; Morais J; Mahaffey KW; Bach RG; Wojdyla D; Wallentin L; Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):680-8. PubMed ID: 22991347 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention. Velders MA; Abtan J; Angiolillo DJ; Ardissino D; Harrington RA; Hellkamp A; Himmelmann A; Husted S; Katus HA; Meier B; Schulte PJ; Storey RF; Wallentin L; Gabriel Steg P; James SK; Heart; 2016 Apr; 102(8):617-25. PubMed ID: 26848185 [TBL] [Abstract][Full Text] [Related]
18. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial. Wallentin L; James S; Storey RF; Armstrong M; Barratt BJ; Horrow J; Husted S; Katus H; Steg PG; Shah SH; Becker RC; Lancet; 2010 Oct; 376(9749):1320-8. PubMed ID: 20801498 [TBL] [Abstract][Full Text] [Related]
19. Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. Shimada YJ; Bansilal S; Wiviott SD; Becker RC; Harrington RA; Himmelmann A; Neely B; Husted S; James SK; Katus HA; Lopes RD; Steg PG; Storey RF; Wallentin L; Cannon CP; Am Heart J; 2016 Jul; 177():1-8. PubMed ID: 27297843 [TBL] [Abstract][Full Text] [Related]
20. Long-term use of ticagrelor in patients with prior myocardial infarction. Bonaca MP; Bhatt DL; Cohen M; Steg PG; Storey RF; Jensen EC; Magnani G; Bansilal S; Fish MP; Im K; Bengtsson O; Oude Ophuis T; Budaj A; Theroux P; Ruda M; Hamm C; Goto S; Spinar J; Nicolau JC; Kiss RG; Murphy SA; Wiviott SD; Held P; Braunwald E; Sabatine MS; N Engl J Med; 2015 May; 372(19):1791-800. PubMed ID: 25773268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]